Company News
 Jim Gibson joins PacBio as chief financial officer
                                                    Jim Gibson joins PacBio as chief financial officer
                                                    Experienced finance leader to help drive company growth and innovation
Jim Gibson joins PacBio as chief financial officer
                                                    Jim Gibson joins PacBio as chief financial officer
                                                    Experienced finance leader to help drive company growth and innovation
                                                
                                                                                                                                                                                                                                                                                
                                         Beamex Group leadership team plan to deliver even greater value to customers
                                                    Beamex Group leadership team plan to deliver even greater value to customers
                                                    Beamex Group leadership team will deliver even greater value to customers with the appointment of two new experienced professionals in sales and operations
Beamex Group leadership team plan to deliver even greater value to customers
                                                    Beamex Group leadership team plan to deliver even greater value to customers
                                                    Beamex Group leadership team will deliver even greater value to customers with the appointment of two new experienced professionals in sales and operations
                                                
                                                                                                                                                                                                                                                                                
                                         Aenova appoints new Managing Director at Regensburg site
                                                    Aenova appoints new Managing Director at Regensburg site
                                                    Dr Nancy Thiels will lead the site with more than 350 employees and focus on the development and production of highly effective solid oral dosage forms
Aenova appoints new Managing Director at Regensburg site
                                                    Aenova appoints new Managing Director at Regensburg site
                                                    Dr Nancy Thiels will lead the site with more than 350 employees and focus on the development and production of highly effective solid oral dosage forms
                                                
                                                                                                                                                                                                                                                                                
                                         Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
                                                    Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
                                                    In this role, he will lead the company’s global Strategy initiatives and CPM functions, and he will be reporting directly to the CEO, serving as a member of the Global...
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
                                                    Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
                                                    In this role, he will lead the company’s global Strategy initiatives and CPM functions, and he will be reporting directly to the CEO, serving as a member of the Global...
                                                
                                                                                                                                                                                                                                                                                
                                         iOnctura strengthens leadership with key executive appointments
                                                    iOnctura strengthens leadership with key executive appointments
                                                    Elizabeth Holt joins as chief business officer, and Dr Mark Velleca appointed board chair
iOnctura strengthens leadership with key executive appointments
                                                    iOnctura strengthens leadership with key executive appointments
                                                    Elizabeth Holt joins as chief business officer, and Dr Mark Velleca appointed board chair
                                                
                                                                                                                                                                                                                                                                                
                                         Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
                                                    Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
                                                    Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor and Laurence Reid joins as Non-Executive Director
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
                                                    Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
                                                    Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor and Laurence Reid joins as Non-Executive Director
                                                
                                                                                                                                                                                                                                                                                
                                         Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer
                                                    Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer
                                                    Cellevate AB is pleased to announce the appointment of Dr. Christel Fenge as Chief Technology Officer (CTO) and member of the management team
Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer
                                                    Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer
                                                    Cellevate AB is pleased to announce the appointment of Dr. Christel Fenge as Chief Technology Officer (CTO) and member of the management team
                                                
                                                                                                                                                                                                                                                                                
                                         Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions
                                                    Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions
                                                    With this appointment, Coriolis strengthens its Board of Directors with additional global expertise from the service sector for the pharmaceutical and biotech industry
Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions
                                                    Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions
                                                    With this appointment, Coriolis strengthens its Board of Directors with additional global expertise from the service sector for the pharmaceutical and biotech industry
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                         Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head
                                                    Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head
                                                    As the CSO, Dr. Ramarao will provide scientific leadership, nurture scientific talent, identify new and emerging capabilities and technologies and focus on green science...
Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head
                                                    Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head
                                                    As the CSO, Dr. Ramarao will provide scientific leadership, nurture scientific talent, identify new and emerging capabilities and technologies and focus on green science...
                                                
                                                                                                                                                                                                                                                                                
                                         Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director
                                                    Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director
                                                    Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive...
Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director
                                                    Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director
                                                    Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive...
                                                
                                                                                                                                                                                                                                                                                
                                         Sygnature Discovery appoints new chief commercial officer
                                                    Sygnature Discovery appoints new chief commercial officer
                                                    Kieron Hall joins to lead commercial strategy and drive business growth
Sygnature Discovery appoints new chief commercial officer
                                                    Sygnature Discovery appoints new chief commercial officer
                                                    Kieron Hall joins to lead commercial strategy and drive business growth
                                                
                                                                                                                                                                                                                                                                                
                                         Selig Group announces planned transition of chief executive officer
                                                    Selig Group announces planned transition of chief executive officer
                                                    Adam Sheridan to take over as CEO from July 1st
Selig Group announces planned transition of chief executive officer
                                                    Selig Group announces planned transition of chief executive officer
                                                    Adam Sheridan to take over as CEO from July 1st
                                                
                                                                                                                                                                                                                                                                                
                                         Abzena appoints Taylor Boyd as chief business officer
                                                    Abzena appoints Taylor Boyd as chief business officer
                                                    New CBO to lead corporate development and strategic growth initiatives
Abzena appoints Taylor Boyd as chief business officer
                                                    Abzena appoints Taylor Boyd as chief business officer
                                                    New CBO to lead corporate development and strategic growth initiatives
                                                
                                                                                                                                                                                                                                                                                
                                         Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
                                                    Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
                                                    Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, announced the promotion of Patrick Meyer, Ph.D., to...
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
                                                    Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
                                                    Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, announced the promotion of Patrick Meyer, Ph.D., to...
                                                
                                                                                                                                                                                                                                                                                
                                         Seth Benson joins Nuclera as Chief Financial Officer
                                                    Seth Benson joins Nuclera as Chief Financial Officer
                                                    This appointment will drive commercial growth of eProtein Discovery and support strategic expansion
Seth Benson joins Nuclera as Chief Financial Officer
                                                    Seth Benson joins Nuclera as Chief Financial Officer
                                                    This appointment will drive commercial growth of eProtein Discovery and support strategic expansion
                                                
                                                                                                                                                                                                                                                                                
                                         Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors
                                                    Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors
                                                    Alongside the 11 other board members, she will implement the company's global growth strategy
Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors
                                                    Thermo Fisher Scientific appoints Karen S. Lynch to its Board of Directors
                                                    Alongside the 11 other board members, she will implement the company's global growth strategy
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                         Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation
                                                    Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation
                                                    This appointment reflects the growing maturity of Eleva’s proprietary pipeline, which includes Eleva’s Factor H (CPV-104) program
Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation
                                                    Eleva appoints Martin Bauer, MD as Chief Medical Officer adding substantial clinical development expertise to the organisation
                                                    This appointment reflects the growing maturity of Eleva’s proprietary pipeline, which includes Eleva’s Factor H (CPV-104) program
                                                
                                                                                                                                                                                                                                                                                
                                         Suj Mehta named CEO of TekniPlex Healthcare
                                                    Suj Mehta named CEO of TekniPlex Healthcare
                                                    Long-tenured senior executive tapped to lead one of company’s two divisions, which develops groundbreaking materials science solutions that transform patient experiences, and...
Suj Mehta named CEO of TekniPlex Healthcare
                                                    Suj Mehta named CEO of TekniPlex Healthcare
                                                    Long-tenured senior executive tapped to lead one of company’s two divisions, which develops groundbreaking materials science solutions that transform patient experiences, and...
                                                
                                                                                                                                                                                                                                                                                
                                         Sapio Sciences expands leadership team to drive growth
                                                    Sapio Sciences expands leadership team to drive growth
                                                    Mike Hampton joins as Chief Commercial Officer, and new scientific office strengthens Sapio’s AI-driven lab informatics leadership
Sapio Sciences expands leadership team to drive growth
                                                    Sapio Sciences expands leadership team to drive growth
                                                    Mike Hampton joins as Chief Commercial Officer, and new scientific office strengthens Sapio’s AI-driven lab informatics leadership
                                                
                                                                                                                                                                                                                                                                                
                                         Nuclera appoints William J. Kullback as Non-Executive Director
                                                    Nuclera appoints William J. Kullback as Non-Executive Director
                                                    Bill will bring more than 30 years of experience to the role, assisting the board in implementing the company's global commercial expansion strategy
Nuclera appoints William J. Kullback as Non-Executive Director
                                                    Nuclera appoints William J. Kullback as Non-Executive Director
                                                    Bill will bring more than 30 years of experience to the role, assisting the board in implementing the company's global commercial expansion strategy
                                                
                                                                                                                                                                                                                                                                                
                                         Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President
                                                    Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President
Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President
                                                    Sygnature Discovery boosts growth of its in vivo pharmacology business with appointment of new Vice President
                                                    
                                                
                                                                                                                                                                                                                                                                                
                                         Cytovation appoints Martin Dewhurst to its Board of Directors
                                                    Cytovation appoints Martin Dewhurst to its Board of Directors
Cytovation appoints Martin Dewhurst to its Board of Directors
                                                    Cytovation appoints Martin Dewhurst to its Board of Directors
                                                    
                                                
                                                                                                                                                                                                                                                                                
                                         Maruho Hatsujyo Group announces key personnel hires to drive business development and marketing
                                                    Maruho Hatsujyo Group announces key personnel hires to drive business development and marketing
Maruho Hatsujyo Group announces key personnel hires to drive business development and marketing
                                                    Maruho Hatsujyo Group announces key personnel hires to drive business development and marketing
                                                    
                                                
                                                                                                                                                                                                                                                                                
                                         Optimal welcomes Sam Henson as Business Development Manager for the Americas
                                                    Optimal welcomes Sam Henson as Business Development Manager for the Americas
                                                    Sam joins the company with a strong academic and technical background, reinforcing Optimal’s commitment to advancing data-driven process control solutions worldwide
Optimal welcomes Sam Henson as Business Development Manager for the Americas
                                                    Optimal welcomes Sam Henson as Business Development Manager for the Americas
                                                    Sam joins the company with a strong academic and technical background, reinforcing Optimal’s commitment to advancing data-driven process control solutions worldwide